x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Oncology News Central Peer-Spectives

Oncololgy News Central

Peer-Spectives is a podcast series that is moderated by Robert Figlin, MD, and features various oncology thought-leaders covering the latest clinical developments in a wide range of tumor types.

science

All Episodes

11:59

Targeted Therapy and Venclexta Combinations for AML...

Oncology News Central Peer-Spectives ·

2021/12/02

Naval Daver, MD, and Robert Figlin, MD, discuss FLT3, TP53, and venetoclax combinations in the management of AML patients and what to look forward to at ASH 2021.

en

11:09

After CodeBreaK100:

Oncology News Central Peer-Spectives ·

2021/11/20

Kathryn Arbour, MD, joins host Robert Figlin, MD, to discuss the importance of the KRAS-targeted drug, sotorasib, in the treatment of non-small cell lung cancer. Kathryn Arbour, MD, joins host Robert Figlin, MD, to discuss the role next-generation sequencing plays in lung cancer care, the responses seen with the KRAS-targeted drug, sotorasib, in CodeBreaK100, and what optimal use of the drug will look like down the road.

en

09:03

ESMO ’21: The ARCHES Study and Progress in Metastatic...

Oncology News Central Peer-Spectives ·

2021/09/22

Andrew Armstrong, MD and Robert Figlin, MD discuss the ARCHES study investigating the role of enzalutamide in metastatic hormone-sensitive prostate cancer, followed by a discussion of the latest treatment trends in non-metastatic hormone-sensitive prostate cancer.

en

11:52

Recent Clinical Progress in Ovarian Cancer

Oncology News Central Peer-Spectives ·

2021/07/16

Robert Coleman, MD and Robert Figlin, MD, discuss the evolving role of bevacizumab in ovarian cancer, recently presented clinical studies such as BOOST and EFFORT, and the challenge of treating the PARP-refractory setting in advanced ovarian cancer.

en

12:47

Post-EHA 2021: Latest Treatment Trends in the...

Oncology News Central Peer-Spectives ·

2021/07/13

en

11:08

Non-Small Cell Lung Cancer Clinical Highlights From...

Oncology News Central Peer-Spectives ·

2021/06/30

Jeffrey Crawford, MD, and Robert Figlin, MD, discuss highlights from ASCO ’21 including immunotherapy, adjuvant and neoadjuvant therapy ie IMpower010 and Checkmate-816, and finish up with a discussion regarding molecular tests, MYLUNG, and NGS as it applies to NSCLC.

en

11:01

Colorectal Cancer Clinical Highlights From ASCO 2021

Oncology News Central Peer-Spectives ·

2021/06/16

Andrew Hendifar, MD, and Robert Figlin, MD, discuss highlights from the 2021 ASCO annual meeting, including immunotherapy in MSI-H/dMMR metastatic CRC patients, looking for DEEPER responses in RAS-wild type tumors, the need for testing for HER2+ CRC patients, and liquid biopsy and the CHRONOS trial.

en

10:23

Breast Cancer Clinical Highlights from ASCO 2021

Oncology News Central Peer-Spectives ·

2021/06/15

Erika Hamilton, MD, of the Sarah Cannon Research Institute, and Robert Figlin, MD, of Cedars-Sinai Medical Center, discuss breast cancer research from the 2021 annual meeting of the American Society of Clinical Oncology, including adjuvant and neo-adjuvant breast cancer, metastatic disease, the role of CDK 4/6 inhibitors and PARP inhibitors, the potential of SERDs, and a negative study.

en

14:28

Non Small Cell Lung Cancer (NSCLC) – Robert Figlin,...

Oncology News Central Peer-Spectives ·

2021/05/20

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center speaks with Melissa Johnson, MD, Program Director, Lung Cancer Research, Sarah Cannon Research Institute, discuss the different driver mutations in Non Small Cell Lung Cancer (NSCLC) and how to use them to guide treatment

en

10:43

Small Cell Lung Cancer (SCLC) – Robert Figlin, MD,...

Oncology News Central Peer-Spectives ·

2021/03/31

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center speaks with Melissa Johnson, MD, Program Director, Lung Cancer Research, Sarah Cannon Research Institute, discuss clinical progress in Small Cell Lung Cancer (SCLC)

en

11:45

Bladder Cancer – Robert Figlin, MD, and Arjun Balar,...

Oncology News Central Peer-Spectives ·

2021/02/28

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Arjun Balar, MD, Director, Genitourinary Medical Oncology Program, NYU Langone's Perlmutter Cancer Center, discuss clinical progress in bladder cancer

en

12:52

Prostate Cancer – Robert Figlin, MD, and Neeraj...

Oncology News Central Peer-Spectives ·

2021/02/22

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Neeraj Agarwal, MD, Professor of Medicine, Huntsman Cancer Institute, Presidential Endowed Chair of Cancer Research , Co-Leader, HCI Experimental Therapeutics Program, Director, Center of Investigational Therapeutics, Director, Genitourinary Oncology Program, Huntsman Cancer Institute, University of Utah, discuss clinical progress in prostate cancer

en

13:36

Renal Cell Carcinoma (RCC) – Robert Figlin, MD and...

Oncology News Central Peer-Spectives ·

2021/02/22

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Toni Choueiri, MD, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, discuss clinical progress in renal cell carcinoma (RCC)

en

12:54

Acute myeloid leukemia (AML) and Acute lymphocytic...

Oncology News Central Peer-Spectives ·

2020/12/22

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and David Sallman, MD, Assistant Member, Department of Malignant Hematology, Moffitt Cancer Center discuss CAR T as it pertains to clinical advances in leukemia

en

10:20

Renal Cell Carcinoma (RCC) – Bradley McGregor, MD,...

Oncology News Central Peer-Spectives ·

2020/10/26

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Bradley McGregor, MD, Clinical Director, Lank Center for Genitourinary Oncology, Professor of Medicine, Harvard Medical School, discuss Checkmate 9ER and other I-O studies as they pertain to the management of RCC patients

en

08:00

Non Small Cell Lung Cancer – Victoria Villaflor, MD,...

Oncology News Central Peer-Spectives ·

2020/10/21

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Victoria Villaflor, MD, Clinical Professor, Director Head and Neck Oncology at City of Hope, discuss unresectable stage III Non Small Cell Lung Cancer (www.azioinpractice.com)

en

13:23

Gastric/GE Junction Cancer – Geoffrey Ku, MD, and...

Oncology News Central Peer-Spectives ·

2020/10/16

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Geoffrey Ku, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center, discuss recent clinical developments in gastric and esophageal cancer

en

15:05

Breast Cancer – Sara Hurvitz, MD, and Robert Figlin,...

Oncology News Central Peer-Spectives ·

2020/07/17

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Sara Hurvitz, MD, Associate Professor of Medicine, Geffen School of Medicine, UCLA, Medical Director, Jonsson Comprehensive Cancer Center Clinical Research Unit, discuss breast cancer patient types, challenges, and treatment advances.

en

10:42

Adjuvant Lung Cancer – Roy Herbst, MD, and Robert...

Oncology News Central Peer-Spectives ·

2020/06/25

Roy Herbst, MD, and Robert Figlin, MD, discuss the implications of the ADAURA study investigating the use of Tagrisso (osimertinib) in stage I-III EGFR+ NSCLC patients

en

09:01

Breast Cancer – Nancy Lin, MD, and Robert Figlin, MD,...

Oncology News Central Peer-Spectives ·

2020/06/12

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Nancy Lin, MD, Associate Professor of Medicine, Harvard Medical School Associate Chief, Division of Breast Oncology Dana-Farber Cancer Institute, discuss novel agents and recent clinical developments in breast cancer

en

134 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter